SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-052116
Filing Date
2020-09-25
Accepted
2020-09-25 17:14:44
Documents
1
Period of Report
2020-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3589
  Complete submission text file 0001209191-20-052116.txt   4966
Mailing Address C/O AUDENTES THERAPEUTICS, INC. 101 MONTGOMERY ST., SUITE 2650 SAN FRANCISCO CA 94104
Business Address
PRASAD SUYASH (Reporting) CIK: 0001679129 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39536 | Film No.: 201200963

Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences